Skip to content
healthcare.dev

Tyvaso DPI

NDC 66302-732, treprostinil, inhalant, from United Therapeutics Corporation.

Product NDC
66302-732
Status
Listed
Labeler
United Therapeutics Corporation
Dosage form
INHALANT
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA214324
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/66302-732 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TREPROSTINIL32 ug/1

Pharmacologic classes

Prostacycline Vasodilator [EPC]; Prostaglandins I [CS]; Vasodilation [PE]

Package NDCNDC-11Package
66302-732-04663020732041 BLISTER PACK in 1 KIT (66302-732-04) / 4 BLISTER PACK in 1 BLISTER PACK / 4 INHALANT in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/ddc3d400-bcb3-4b09-aae2-0768b10a5b0f

Use it

Look up 66302-732 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/66302-732 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 66302-732. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.